Study of Patient Satisfaction With the Cancer Clinical Trial Experience

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Joyce Neading, Summa Health System
ClinicalTrials.gov Identifier:
NCT00768976
First received: October 7, 2008
Last updated: May 22, 2012
Last verified: May 2012

October 7, 2008
May 22, 2012
October 2008
May 2012   (final data collection date for primary outcome measure)
Evaluation of surveys to determine if there are opportunities for performance and/or quality improvement projects.patient satisfaction regarding reasons for participating, facility, consent and treatment, personal issues and overall assessment. [ Time Frame: Survey will be sent to subject 3 months after study registration ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00768976 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Study of Patient Satisfaction With the Cancer Clinical Trial Experience
Study of Patient Satisfaction With the Cancer Clinical Trial Experience

The primary objective of this study is to evaluate the quality of the clinical trial experience of cancer patients participating in cancer research studies through Summa Health System Hospitals Cancer Research Program by evaluating patient satisfaction regarding reasons for participating, facility, consent and treatment, personal issues and overall assessment.

The secondary objective of this study is to determine areas for improvement to make the patient's clinical trial experience a satisfying and positive journey.

Not Provided
Observational
Observational Model: Ecologic or Community
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Participant must have participated in a clinical trial conducted by the Summa Health System Hospitals Cancer Research Program.

Cancer
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
100
May 2012
May 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Participant must have participated in a clinical trial conducted by the Summa Health System Hospitals Cancer Research Program.
  • Participant should have been registered for clinical trial participation three months prior to receiving the satisfaction survey.

Exclusion Criteria:

  • Participant has withdrawn consent for clinical trial participation and/or follow up.
  • Participant has a major medical illness that would prevent completion of the survey.
Both
18 Years to 80 Years
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00768976
Clinical trial experience
No
Joyce Neading, Summa Health System
Summa Health System
Not Provided
Principal Investigator: Joyce Neading, RHIT, CTR Summa Health System
Summa Health System
May 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP